glp 1 gambling A turning point in addiction psychiatry? | School of Public Health My GLP-1 Journey | Leader's

In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group

Some states have rules that require you to visit your doctor or pharmacist before getting refills

No clinic visit

Very low-carb diets arent necessary and may increase fatigue

How should tirzepatide be stored and handled